General Information of the Compound
Compound ID |
CP0002778
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
Show/Hide
|
||||||||||||||||||
Synonyms |
112GI019
152459-95-5
BKJ8M8G5HI
CCRIS 9076
CGP-57148
CHEMBL941
Cgp 57148
Glamox
Glamox (TN)
Gleevec (TN)
Glivec (TN)
Imatinib
Imatinib (INN)
Imatinib (STI571)
Imatinib Methansulfonate
Imatinib [INN:BAN]
Imatinib free base
STI
UNII-BKJ8M8G5HI
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C29H31N7O
|
||||||||||||||||||
Molecular Weight |
493.615
|
||||||||||||||||||
Canonical SMILES |
CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34)
Show/Hide
|
||||||||||||||||||
InChIKey |
KTUFNOKKBVMGRW-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
152459-95-5
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01546, ATP-dependent translocase ABCB1
Protein ID: PT00649, BCR/ABL p210 fusion protein
Protein ID: PT04542, Bile salt export pump
Protein ID: PT02718, Broad substrate specificity ATP-binding cassette transporter ABCG2
Cell-based Assay
Protein ID: PT01678, Discoidin domain-containing receptor 2
Protein ID: PT02113, Epithelial discoidin domain-containing receptor 1
Protein ID: PT06109, Geminin
Protein ID: PT00991, Histone deacetylase 1
Protein ID: PT01213, Histone deacetylase 6
Protein ID: PT01008, Macrophage colony-stimulating factor 1 receptor
Protein ID: PT00888, Mast/stem cell growth factor receptor Kit
Cell-based Assay
Biochemical Assays
Protein ID: PT05367, Multidrug and toxin extrusion protein 1
Protein ID: PT05330, Multidrug and toxin extrusion protein 2
Protein ID: PT01092, Platelet-derived growth factor receptor alpha
Cell-based Assay
Protein ID: PT00844, Platelet-derived growth factor receptor beta
Protein ID: PT05989, Platelet-derived growth factor receptor beta
Protein ID: PT01204, Receptor-type tyrosine-protein kinase FLT3
Protein ID: PT04591, Solute carrier family 22 member 2
Protein ID: PT06607, Solute carrier family 22 member 3
Protein ID: PT01071, Tyrosine-protein kinase ABL1
Cell-based Assay
Biochemical Assays
Protein ID: PT03338, Tyrosine-protein kinase ABL1
Protein ID: PT01654, Tyrosine-protein kinase Blk
Protein ID: PT00876, Tyrosine-protein kinase Lck
Protein ID: PT00875, Tyrosine-protein kinase Lyn
Protein ID: PT00864, Vascular endothelial growth factor receptor 2
Cell Viability or Cytotoxicity Assay
Clinical Information about the Compound
Drug 1 ( Imatinib )
Drug Name | Imatinib | ||
---|---|---|---|
Company | Novartis AG | ||
Indication | |||
Target(s) |